THC content has been the sole indicator of a strain’s potency and quality, but this is changing as the merits of the other cannabinoids, and particularly CBD, are being scientifically recognised. THC has shown to hold its own qualities, but it is CBD that has moved into the spotlight for its wide range of qualities. Particularly the absence of any psychoactive effects makes CBD attractive for a wide range of applications like treatment of anxiety, insomnia, pain, Alzheimer’s, epilepsy and glaucoma are just a few of the conditions CBD seems to be able to assist.
Cannatonic is an award winning CBD-rich strain that is made up of 50 percent sativa genetics and 50 percent indica genetics. The strain was created via the crossbreeding of parent strains Reina Madre and NYCD. The strain is capable of producing strains with a THC:CBD ratio of 1:1 which is ideal for medical users looking for a high CBD strain that will still offer the medicinal benefits of THC.
2. Fast Eddy
To produce this strain, breeders hybridized Cheese, Juanita La Lagrimosa, and ruderalis plants into a single autoflowering hybrid. Fast Eddy develops around 9% of THC, which is a small amount, but significant enough to induce psychoactive effects. It also develops high CBD-levels, which complements the experience with superb entourage effects.
CBD-Chronic is an indica and sativa hybrid cannabis strain that is the result of the crossbreeding of parent strains Chronic and Remedy. The THC:CBD ratio of plants is nearly a perfect 1:1. THC levels within the flowers are reported to be around 5.1 percent, whereas CBD levels are a tiny bit higher at 5.8 percent. This balance allows for a calm and gentle high augmented by the medicinal power of CBD.